nodes	percent_of_prediction	percent_of_DWPC	metapath
Cyclizine—Altered state of consciousness—Cladribine—multiple sclerosis	0.0384	0.0384	CcSEcCtD
Cyclizine—Injection site reaction—Cladribine—multiple sclerosis	0.0176	0.0176	CcSEcCtD
Cyclizine—Depressed level of consciousness—Cladribine—multiple sclerosis	0.0171	0.0171	CcSEcCtD
Cyclizine—Jaundice cholestatic—Azathioprine—multiple sclerosis	0.0164	0.0164	CcSEcCtD
Cyclizine—Connective tissue disorder—Fingolimod—multiple sclerosis	0.0154	0.0154	CcSEcCtD
Cyclizine—Eye disorder—Fingolimod—multiple sclerosis	0.0147	0.0147	CcSEcCtD
Cyclizine—Disorientation—Cladribine—multiple sclerosis	0.0144	0.0144	CcSEcCtD
Cyclizine—Mental disorder—Fingolimod—multiple sclerosis	0.0138	0.0138	CcSEcCtD
Cyclizine—Blister—Prednisolone—multiple sclerosis	0.0133	0.0133	CcSEcCtD
Cyclizine—Vision blurred—Fingolimod—multiple sclerosis	0.0129	0.0129	CcSEcCtD
Cyclizine—Blister—Triamcinolone—multiple sclerosis	0.0122	0.0122	CcSEcCtD
Cyclizine—Hepatic function abnormal—Azathioprine—multiple sclerosis	0.012	0.012	CcSEcCtD
Cyclizine—Hypertension—Fingolimod—multiple sclerosis	0.0118	0.0118	CcSEcCtD
Cyclizine—Blister—Betamethasone—multiple sclerosis	0.0111	0.0111	CcSEcCtD
Cyclizine—Blister—Dexamethasone—multiple sclerosis	0.0111	0.0111	CcSEcCtD
Cyclizine—Nervous system disorder—Fingolimod—multiple sclerosis	0.0109	0.0109	CcSEcCtD
Cyclizine—Skin disorder—Fingolimod—multiple sclerosis	0.0108	0.0108	CcSEcCtD
Cyclizine—Hypotension—Fingolimod—multiple sclerosis	0.0104	0.0104	CcSEcCtD
Cyclizine—Paraesthesia—Fingolimod—multiple sclerosis	0.01	0.01	CcSEcCtD
Cyclizine—Hepatobiliary disease—Cladribine—multiple sclerosis	0.00938	0.00938	CcSEcCtD
Cyclizine—Connective tissue disorder—Cladribine—multiple sclerosis	0.00875	0.00875	CcSEcCtD
Cyclizine—Eye disorder—Cladribine—multiple sclerosis	0.00832	0.00832	CcSEcCtD
Cyclizine—Thrombophlebitis—Prednisolone—multiple sclerosis	0.00801	0.00802	CcSEcCtD
Cyclizine—Asthenia—Fingolimod—multiple sclerosis	0.008	0.00801	CcSEcCtD
Cyclizine—Chills—Cladribine—multiple sclerosis	0.00799	0.00799	CcSEcCtD
Cyclizine—Pruritus—Fingolimod—multiple sclerosis	0.00789	0.0079	CcSEcCtD
Cyclizine—Mental disorder—Cladribine—multiple sclerosis	0.0078	0.0078	CcSEcCtD
Cyclizine—Erythema—Cladribine—multiple sclerosis	0.00775	0.00775	CcSEcCtD
Cyclizine—Hepatobiliary disease—Azathioprine—multiple sclerosis	0.00762	0.00763	CcSEcCtD
Cyclizine—Agranulocytosis—Azathioprine—multiple sclerosis	0.00752	0.00753	CcSEcCtD
Cyclizine—Dizziness—Fingolimod—multiple sclerosis	0.00738	0.00738	CcSEcCtD
Cyclizine—Thrombophlebitis—Triamcinolone—multiple sclerosis	0.00737	0.00737	CcSEcCtD
Cyclizine—Thrombophlebitis—Methylprednisolone—multiple sclerosis	0.00735	0.00736	CcSEcCtD
Cyclizine—Dermatitis bullous—Prednisolone—multiple sclerosis	0.00726	0.00726	CcSEcCtD
Cyclizine—Headache—Fingolimod—multiple sclerosis	0.00699	0.00699	CcSEcCtD
Cyclizine—Apnoea—Methotrexate—multiple sclerosis	0.00685	0.00685	CcSEcCtD
Cyclizine—Speech disorder—Methotrexate—multiple sclerosis	0.00675	0.00675	CcSEcCtD
Cyclizine—Thrombophlebitis—Dexamethasone—multiple sclerosis	0.00669	0.00669	CcSEcCtD
Cyclizine—Thrombophlebitis—Betamethasone—multiple sclerosis	0.00669	0.00669	CcSEcCtD
Cyclizine—Dermatitis bullous—Triamcinolone—multiple sclerosis	0.00668	0.00668	CcSEcCtD
Cyclizine—Drowsiness—Mitoxantrone—multiple sclerosis	0.00652	0.00652	CcSEcCtD
Cyclizine—Chills—Azathioprine—multiple sclerosis	0.00649	0.0065	CcSEcCtD
Cyclizine—Nervous system disorder—Cladribine—multiple sclerosis	0.0062	0.0062	CcSEcCtD
Cyclizine—Tachycardia—Cladribine—multiple sclerosis	0.00617	0.00617	CcSEcCtD
Cyclizine—Skin disorder—Cladribine—multiple sclerosis	0.00614	0.00614	CcSEcCtD
Cyclizine—Agranulocytosis—Mitoxantrone—multiple sclerosis	0.00608	0.00608	CcSEcCtD
Cyclizine—Dermatitis bullous—Betamethasone—multiple sclerosis	0.00606	0.00606	CcSEcCtD
Cyclizine—Dermatitis bullous—Dexamethasone—multiple sclerosis	0.00606	0.00606	CcSEcCtD
Cyclizine—Hypotension—Cladribine—multiple sclerosis	0.00591	0.00591	CcSEcCtD
Cyclizine—Hepatitis—Mitoxantrone—multiple sclerosis	0.00585	0.00585	CcSEcCtD
Cyclizine—Thrombophlebitis—Prednisone—multiple sclerosis	0.00582	0.00583	CcSEcCtD
Cyclizine—Insomnia—Cladribine—multiple sclerosis	0.00572	0.00572	CcSEcCtD
Cyclizine—Paraesthesia—Cladribine—multiple sclerosis	0.00568	0.00568	CcSEcCtD
Cyclizine—Somnolence—Cladribine—multiple sclerosis	0.00562	0.00562	CcSEcCtD
Cyclizine—Depressed level of consciousness—Methotrexate—multiple sclerosis	0.0056	0.00561	CcSEcCtD
Cyclizine—Bronchospasm—Methylprednisolone—multiple sclerosis	0.00541	0.00541	CcSEcCtD
Cyclizine—Pain—Cladribine—multiple sclerosis	0.00541	0.00541	CcSEcCtD
Cyclizine—Constipation—Cladribine—multiple sclerosis	0.00541	0.00541	CcSEcCtD
Cyclizine—Chills—Mitoxantrone—multiple sclerosis	0.00525	0.00525	CcSEcCtD
Cyclizine—Erythema—Mitoxantrone—multiple sclerosis	0.00509	0.00509	CcSEcCtD
Cyclizine—Urticaria—Cladribine—multiple sclerosis	0.00502	0.00503	CcSEcCtD
Cyclizine—Skin disorder—Azathioprine—multiple sclerosis	0.00499	0.005	CcSEcCtD
Cyclizine—Thrombophlebitis—Methotrexate—multiple sclerosis	0.00487	0.00487	CcSEcCtD
Cyclizine—Hypotension—Azathioprine—multiple sclerosis	0.0048	0.00481	CcSEcCtD
Cyclizine—Vision blurred—Mitoxantrone—multiple sclerosis	0.0048	0.0048	CcSEcCtD
Cyclizine—Hypersensitivity—Cladribine—multiple sclerosis	0.00466	0.00466	CcSEcCtD
Cyclizine—Asthenia—Cladribine—multiple sclerosis	0.00454	0.00454	CcSEcCtD
Cyclizine—Pruritus—Cladribine—multiple sclerosis	0.00447	0.00448	CcSEcCtD
Cyclizine—Convulsion—Mitoxantrone—multiple sclerosis	0.00441	0.00441	CcSEcCtD
Cyclizine—Hypertension—Mitoxantrone—multiple sclerosis	0.0044	0.0044	CcSEcCtD
Cyclizine—Connective tissue disorder—Methylprednisolone—multiple sclerosis	0.00433	0.00433	CcSEcCtD
Cyclizine—Dizziness—Cladribine—multiple sclerosis	0.00418	0.00418	CcSEcCtD
Cyclizine—Erythema—Prednisolone—multiple sclerosis	0.00418	0.00418	CcSEcCtD
Cyclizine—Anaphylactic shock—Mitoxantrone—multiple sclerosis	0.00416	0.00416	CcSEcCtD
Cyclizine—Eye disorder—Methylprednisolone—multiple sclerosis	0.00412	0.00412	CcSEcCtD
Cyclizine—Tachycardia—Mitoxantrone—multiple sclerosis	0.00406	0.00406	CcSEcCtD
Cyclizine—Skin disorder—Mitoxantrone—multiple sclerosis	0.00404	0.00404	CcSEcCtD
Cyclizine—Headache—Cladribine—multiple sclerosis	0.00396	0.00396	CcSEcCtD
Cyclizine—Vision blurred—Prednisolone—multiple sclerosis	0.00394	0.00394	CcSEcCtD
Cyclizine—Hypotension—Mitoxantrone—multiple sclerosis	0.00388	0.00389	CcSEcCtD
Cyclizine—Mental disorder—Methylprednisolone—multiple sclerosis	0.00386	0.00386	CcSEcCtD
Cyclizine—Erythema—Triamcinolone—multiple sclerosis	0.00384	0.00384	CcSEcCtD
Cyclizine—Erythema—Methylprednisolone—multiple sclerosis	0.00383	0.00384	CcSEcCtD
Cyclizine—Angioedema—Prednisolone—multiple sclerosis	0.00382	0.00382	CcSEcCtD
Cyclizine—Hypersensitivity—Azathioprine—multiple sclerosis	0.00379	0.00379	CcSEcCtD
Cyclizine—Eye disorder—Dexamethasone—multiple sclerosis	0.00374	0.00374	CcSEcCtD
Cyclizine—Eye disorder—Betamethasone—multiple sclerosis	0.00374	0.00374	CcSEcCtD
Cyclizine—Paraesthesia—Mitoxantrone—multiple sclerosis	0.00373	0.00373	CcSEcCtD
Cyclizine—Somnolence—Mitoxantrone—multiple sclerosis	0.0037	0.0037	CcSEcCtD
Cyclizine—Convulsion—Prednisolone—multiple sclerosis	0.00362	0.00362	CcSEcCtD
Cyclizine—Hypertension—Prednisolone—multiple sclerosis	0.00361	0.00361	CcSEcCtD
Cyclizine—Constipation—Mitoxantrone—multiple sclerosis	0.00355	0.00356	CcSEcCtD
Cyclizine—Pain—Mitoxantrone—multiple sclerosis	0.00355	0.00356	CcSEcCtD
Cyclizine—Angioedema—Triamcinolone—multiple sclerosis	0.00351	0.00351	CcSEcCtD
Cyclizine—Angioedema—Methylprednisolone—multiple sclerosis	0.0035	0.0035	CcSEcCtD
Cyclizine—Erythema—Betamethasone—multiple sclerosis	0.00349	0.00349	CcSEcCtD
Cyclizine—Erythema—Dexamethasone—multiple sclerosis	0.00349	0.00349	CcSEcCtD
Cyclizine—Connective tissue disorder—Prednisone—multiple sclerosis	0.00343	0.00343	CcSEcCtD
Cyclizine—Anaphylactic shock—Prednisolone—multiple sclerosis	0.00341	0.00341	CcSEcCtD
Cyclizine—Dizziness—Azathioprine—multiple sclerosis	0.0034	0.0034	CcSEcCtD
Cyclizine—Convulsion—Triamcinolone—multiple sclerosis	0.00333	0.00333	CcSEcCtD
Cyclizine—Tachycardia—Prednisolone—multiple sclerosis	0.00333	0.00333	CcSEcCtD
Cyclizine—Convulsion—Methylprednisolone—multiple sclerosis	0.00332	0.00332	CcSEcCtD
Cyclizine—Hypertension—Triamcinolone—multiple sclerosis	0.00332	0.00332	CcSEcCtD
Cyclizine—Hypertension—Methylprednisolone—multiple sclerosis	0.00331	0.00331	CcSEcCtD
Cyclizine—Urticaria—Mitoxantrone—multiple sclerosis	0.0033	0.0033	CcSEcCtD
Cyclizine—Eye disorder—Prednisone—multiple sclerosis	0.00326	0.00326	CcSEcCtD
Cyclizine—Drowsiness—Methotrexate—multiple sclerosis	0.00325	0.00325	CcSEcCtD
Cyclizine—Headache—Azathioprine—multiple sclerosis	0.00322	0.00322	CcSEcCtD
Cyclizine—Angioedema—Dexamethasone—multiple sclerosis	0.00319	0.00319	CcSEcCtD
Cyclizine—Angioedema—Betamethasone—multiple sclerosis	0.00319	0.00319	CcSEcCtD
Cyclizine—Anaphylactic shock—Triamcinolone—multiple sclerosis	0.00314	0.00314	CcSEcCtD
Cyclizine—Anaphylactic shock—Methylprednisolone—multiple sclerosis	0.00313	0.00313	CcSEcCtD
Cyclizine—Insomnia—Prednisolone—multiple sclerosis	0.00308	0.00309	CcSEcCtD
Cyclizine—Hepatobiliary disease—Methotrexate—multiple sclerosis	0.00307	0.00307	CcSEcCtD
Cyclizine—Nervous system disorder—Methylprednisolone—multiple sclerosis	0.00307	0.00307	CcSEcCtD
Cyclizine—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.00306	0.00306	CcSEcCtD
Cyclizine—Paraesthesia—Prednisolone—multiple sclerosis	0.00306	0.00306	CcSEcCtD
Cyclizine—Tachycardia—Triamcinolone—multiple sclerosis	0.00306	0.00306	CcSEcCtD
Cyclizine—Mental disorder—Prednisone—multiple sclerosis	0.00306	0.00306	CcSEcCtD
Cyclizine—Tachycardia—Methylprednisolone—multiple sclerosis	0.00305	0.00305	CcSEcCtD
Cyclizine—Skin disorder—Methylprednisolone—multiple sclerosis	0.00304	0.00304	CcSEcCtD
Cyclizine—Erythema—Prednisone—multiple sclerosis	0.00304	0.00304	CcSEcCtD
Cyclizine—Agranulocytosis—Methotrexate—multiple sclerosis	0.00303	0.00303	CcSEcCtD
Cyclizine—Convulsion—Dexamethasone—multiple sclerosis	0.00302	0.00302	CcSEcCtD
Cyclizine—Convulsion—Betamethasone—multiple sclerosis	0.00302	0.00302	CcSEcCtD
Cyclizine—Hypertension—Dexamethasone—multiple sclerosis	0.00301	0.00301	CcSEcCtD
Cyclizine—Hypertension—Betamethasone—multiple sclerosis	0.00301	0.00301	CcSEcCtD
Cyclizine—Asthenia—Mitoxantrone—multiple sclerosis	0.00298	0.00298	CcSEcCtD
Cyclizine—Hypotension—Methylprednisolone—multiple sclerosis	0.00292	0.00292	CcSEcCtD
Cyclizine—Pain—Prednisolone—multiple sclerosis	0.00292	0.00292	CcSEcCtD
Cyclizine—Hepatitis—Methotrexate—multiple sclerosis	0.00291	0.00292	CcSEcCtD
Cyclizine—Vision blurred—Prednisone—multiple sclerosis	0.00286	0.00286	CcSEcCtD
Cyclizine—Anaphylactic shock—Betamethasone—multiple sclerosis	0.00285	0.00285	CcSEcCtD
Cyclizine—Anaphylactic shock—Dexamethasone—multiple sclerosis	0.00285	0.00285	CcSEcCtD
Cyclizine—Insomnia—Triamcinolone—multiple sclerosis	0.00284	0.00284	CcSEcCtD
Cyclizine—Insomnia—Methylprednisolone—multiple sclerosis	0.00283	0.00283	CcSEcCtD
Cyclizine—Paraesthesia—Triamcinolone—multiple sclerosis	0.00282	0.00282	CcSEcCtD
Cyclizine—Paraesthesia—Methylprednisolone—multiple sclerosis	0.00281	0.00281	CcSEcCtD
Cyclizine—Nervous system disorder—Dexamethasone—multiple sclerosis	0.00279	0.00279	CcSEcCtD
Cyclizine—Nervous system disorder—Betamethasone—multiple sclerosis	0.00279	0.00279	CcSEcCtD
Cyclizine—Agitation—Prednisone—multiple sclerosis	0.00279	0.00279	CcSEcCtD
Cyclizine—Tachycardia—Dexamethasone—multiple sclerosis	0.00278	0.00278	CcSEcCtD
Cyclizine—Tachycardia—Betamethasone—multiple sclerosis	0.00278	0.00278	CcSEcCtD
Cyclizine—Angioedema—Prednisone—multiple sclerosis	0.00277	0.00278	CcSEcCtD
Cyclizine—Eye disorder—Methotrexate—multiple sclerosis	0.00272	0.00273	CcSEcCtD
Cyclizine—Urticaria—Prednisolone—multiple sclerosis	0.00271	0.00271	CcSEcCtD
Cyclizine—Pain—Triamcinolone—multiple sclerosis	0.00268	0.00268	CcSEcCtD
Cyclizine—Hypotension—Dexamethasone—multiple sclerosis	0.00266	0.00266	CcSEcCtD
Cyclizine—Hypotension—Betamethasone—multiple sclerosis	0.00266	0.00266	CcSEcCtD
Cyclizine—Convulsion—Prednisone—multiple sclerosis	0.00263	0.00263	CcSEcCtD
Cyclizine—Hypertension—Prednisone—multiple sclerosis	0.00262	0.00262	CcSEcCtD
Cyclizine—Chills—Methotrexate—multiple sclerosis	0.00262	0.00262	CcSEcCtD
Cyclizine—Headache—Mitoxantrone—multiple sclerosis	0.0026	0.0026	CcSEcCtD
Cyclizine—Insomnia—Dexamethasone—multiple sclerosis	0.00257	0.00257	CcSEcCtD
Cyclizine—Insomnia—Betamethasone—multiple sclerosis	0.00257	0.00257	CcSEcCtD
Cyclizine—Paraesthesia—Dexamethasone—multiple sclerosis	0.00255	0.00256	CcSEcCtD
Cyclizine—Paraesthesia—Betamethasone—multiple sclerosis	0.00255	0.00256	CcSEcCtD
Cyclizine—Mental disorder—Methotrexate—multiple sclerosis	0.00255	0.00255	CcSEcCtD
Cyclizine—Erythema—Methotrexate—multiple sclerosis	0.00254	0.00254	CcSEcCtD
Cyclizine—Hypersensitivity—Prednisolone—multiple sclerosis	0.00251	0.00251	CcSEcCtD
Cyclizine—Urticaria—Triamcinolone—multiple sclerosis	0.00249	0.00249	CcSEcCtD
Cyclizine—Urticaria—Methylprednisolone—multiple sclerosis	0.00249	0.00249	CcSEcCtD
Cyclizine—Anaphylactic shock—Prednisone—multiple sclerosis	0.00248	0.00248	CcSEcCtD
Cyclizine—Pain—Dexamethasone—multiple sclerosis	0.00243	0.00243	CcSEcCtD
Cyclizine—Pain—Betamethasone—multiple sclerosis	0.00243	0.00243	CcSEcCtD
Cyclizine—Nervous system disorder—Prednisone—multiple sclerosis	0.00243	0.00243	CcSEcCtD
Cyclizine—Tachycardia—Prednisone—multiple sclerosis	0.00242	0.00242	CcSEcCtD
Cyclizine—Skin disorder—Prednisone—multiple sclerosis	0.00241	0.00241	CcSEcCtD
Cyclizine—Vision blurred—Methotrexate—multiple sclerosis	0.00239	0.00239	CcSEcCtD
Cyclizine—Hypersensitivity—Triamcinolone—multiple sclerosis	0.00231	0.00231	CcSEcCtD
Cyclizine—Hypersensitivity—Methylprednisolone—multiple sclerosis	0.00231	0.00231	CcSEcCtD
Cyclizine—Urticaria—Betamethasone—multiple sclerosis	0.00226	0.00226	CcSEcCtD
Cyclizine—Urticaria—Dexamethasone—multiple sclerosis	0.00226	0.00226	CcSEcCtD
Cyclizine—Dizziness—Prednisolone—multiple sclerosis	0.00225	0.00226	CcSEcCtD
Cyclizine—Asthenia—Triamcinolone—multiple sclerosis	0.00225	0.00225	CcSEcCtD
Cyclizine—Asthenia—Methylprednisolone—multiple sclerosis	0.00224	0.00225	CcSEcCtD
Cyclizine—Insomnia—Prednisone—multiple sclerosis	0.00224	0.00224	CcSEcCtD
Cyclizine—Paraesthesia—Prednisone—multiple sclerosis	0.00223	0.00223	CcSEcCtD
Cyclizine—Pruritus—Triamcinolone—multiple sclerosis	0.00222	0.00222	CcSEcCtD
Cyclizine—Pruritus—Methylprednisolone—multiple sclerosis	0.00221	0.00221	CcSEcCtD
Cyclizine—Convulsion—Methotrexate—multiple sclerosis	0.0022	0.0022	CcSEcCtD
Cyclizine—Headache—Prednisolone—multiple sclerosis	0.00214	0.00214	CcSEcCtD
Cyclizine—Constipation—Prednisone—multiple sclerosis	0.00212	0.00212	CcSEcCtD
Cyclizine—Dizziness—Triamcinolone—multiple sclerosis	0.00207	0.00207	CcSEcCtD
Cyclizine—Anaphylactic shock—Methotrexate—multiple sclerosis	0.00207	0.00207	CcSEcCtD
Cyclizine—Dizziness—Methylprednisolone—multiple sclerosis	0.00207	0.00207	CcSEcCtD
Cyclizine—Asthenia—Betamethasone—multiple sclerosis	0.00204	0.00204	CcSEcCtD
Cyclizine—Asthenia—Dexamethasone—multiple sclerosis	0.00204	0.00204	CcSEcCtD
Cyclizine—Nervous system disorder—Methotrexate—multiple sclerosis	0.00203	0.00203	CcSEcCtD
Cyclizine—Pruritus—Betamethasone—multiple sclerosis	0.00201	0.00201	CcSEcCtD
Cyclizine—Pruritus—Dexamethasone—multiple sclerosis	0.00201	0.00201	CcSEcCtD
Cyclizine—Skin disorder—Methotrexate—multiple sclerosis	0.00201	0.00201	CcSEcCtD
Cyclizine—Urticaria—Prednisone—multiple sclerosis	0.00197	0.00197	CcSEcCtD
Cyclizine—Headache—Triamcinolone—multiple sclerosis	0.00196	0.00197	CcSEcCtD
Cyclizine—Headache—Methylprednisolone—multiple sclerosis	0.00196	0.00196	CcSEcCtD
Cyclizine—Hypotension—Methotrexate—multiple sclerosis	0.00194	0.00194	CcSEcCtD
Cyclizine—Dizziness—Dexamethasone—multiple sclerosis	0.00188	0.00188	CcSEcCtD
Cyclizine—Dizziness—Betamethasone—multiple sclerosis	0.00188	0.00188	CcSEcCtD
Cyclizine—Insomnia—Methotrexate—multiple sclerosis	0.00187	0.00187	CcSEcCtD
Cyclizine—Paraesthesia—Methotrexate—multiple sclerosis	0.00186	0.00186	CcSEcCtD
Cyclizine—Somnolence—Methotrexate—multiple sclerosis	0.00184	0.00184	CcSEcCtD
Cyclizine—Hypersensitivity—Prednisone—multiple sclerosis	0.00183	0.00183	CcSEcCtD
Cyclizine—Headache—Dexamethasone—multiple sclerosis	0.00178	0.00178	CcSEcCtD
Cyclizine—Headache—Betamethasone—multiple sclerosis	0.00178	0.00178	CcSEcCtD
Cyclizine—Asthenia—Prednisone—multiple sclerosis	0.00178	0.00178	CcSEcCtD
Cyclizine—Pain—Methotrexate—multiple sclerosis	0.00177	0.00177	CcSEcCtD
Cyclizine—Pruritus—Prednisone—multiple sclerosis	0.00175	0.00175	CcSEcCtD
Cyclizine—Urticaria—Methotrexate—multiple sclerosis	0.00165	0.00165	CcSEcCtD
Cyclizine—Dizziness—Prednisone—multiple sclerosis	0.00164	0.00164	CcSEcCtD
Cyclizine—Headache—Prednisone—multiple sclerosis	0.00155	0.00155	CcSEcCtD
Cyclizine—Hypersensitivity—Methotrexate—multiple sclerosis	0.00153	0.00153	CcSEcCtD
Cyclizine—Asthenia—Methotrexate—multiple sclerosis	0.00149	0.00149	CcSEcCtD
Cyclizine—Pruritus—Methotrexate—multiple sclerosis	0.00147	0.00147	CcSEcCtD
Cyclizine—Dizziness—Methotrexate—multiple sclerosis	0.00137	0.00137	CcSEcCtD
Cyclizine—Headache—Methotrexate—multiple sclerosis	0.0013	0.0013	CcSEcCtD
Cyclizine—Trimethaphan—BCHE—multiple sclerosis	0.000314	0.788	CrCbGaD
Cyclizine—Phenprocoumon—ALB—multiple sclerosis	8.47e-05	0.212	CrCbGaD
